Secor Alicia

Zevra Therapeutics, Inc. · Director

Secor Alicia is listed in filings as Director at Zevra Therapeutics, Inc.. This profile follows SEC Form 4 activity through Dec 9, 2025, including 8 public disclosures. Recent filings connect the profile to Zevra Therapeutics, Inc. (ZVRA) and G1 Therapeutics, Inc. (GTHX). The current snapshot covers public activity from Jun 14, 2024 to Dec 9, 2025. Reported amounts are shown as $367.6K to $143.0K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.

Data sources and methodology

Latest Trades

CompanyValueActionPriceCurrent Price
No direct insider buys or sells are available yet.